Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Slides:



Advertisements
Similar presentations
Elizabeth A. David, MD, David T
Advertisements

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Sublobar Resection for Pulmonary Aspergilloma: A Safe Alternative to Lobectomy  Ping Yuan, MD, Jin-Lin Cao, MD, Sha Huang, MD, Chong Zhang, MD, Fei-Chao.
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in.
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Collision Tumor of Esophagus: Report of Three Cases
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Puja Gaur, MD, Wayne L. Hofstetter, MD, B
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.
Andrew Feber, PhD, Liqiang Xi, MD, PhD, Arjun Pennathur, MD, William E
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations  Giovanni Filardo, PhD, MPH, Paul.
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery  Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.
Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections  Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.
Castigliano M. Bhamidipati, DO, MS, George J
Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Operative Results and Outcomes in Children With Shone's Anomaly
Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer  Servet Bölükbas,
Appraisal of a Revised Lymph Node Classification System for Esophageal Squamous Cell Cancer  Dipok Kumar Dhar, PhD, Shinji Hattori, MD, Yasuhito Tonomoto,
Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K
Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases  Haifeng Wang, MM, Hongsheng Lin, MM, Gening.
Lung Cancer Surgery in Patients With Liver Cirrhosis
Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery  James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,
Karam Nam, MD, Yoon Sang Park, MD, Won Ho Kim, MD, PhD 
Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer  Zhenfa Zhang, MD, Jianqun Ma, MD, Ni Li, PhD, Nan Sun, MD,
Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis  Shahid I. Sheikh, MD, Don Hayes,
Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma  Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.
Use of Amiodarone After Major Lung Resection
Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E
Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence  Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,
Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.
Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer  Raymond U.
The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection  Po-Kuei Hsu, MD, Chien-Sheng Huang,
Felix G. Fernandez, MD, Onkar Khullar, MD, Seth D
Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy  Feng Wang, MD, Yuzhen Zheng, MD, Zhen Wang,
Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D
Radiofrequency Ablation for the Treatment of Pulmonary Metastases
Intrathoracic Lymph Node Metastases From Extrathoracic Carcinoma: The Place for Surgery  Marc Riquet, MD, Pascal Berna, MD, Emmanuel Brian, MD, Alain.
Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy  Pamela Samson, MD, MPHS,
Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer  Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.
Characteristics of Malignant Pleural Mesothelioma in Women
Surgical Treatment for Limited-Stage Primary Small Cell Cancer of the Esophagus  Dongrong Situ, MD, Yongbin Lin, MD, PhD, Hao Long, MD, PhD, Lanjun Zhang,
Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival  Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,
Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations  Jun Peng, MD, Wen-Ping Wang, MD, Ting Dong, MD, Jie Cai,
A. Thomas Pezzella, MD, Sari D
A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection  Shiro Nagatani, MD, Yutaka Shimada,
Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer  Pamela Samson, MD, MPHS, Varun.
Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?  Anna Lee, MD, MPH, Andrew T.
Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study  Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,
Reduced Acetylated Histone H4 is Associated With Promoter Methylation of the Fragile Histidine Triad Gene in Resected Esophageal Squamous Cell Carcinoma 
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population  Christian McNeely, MD, Stephen.
Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival  Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,
Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases  Yukinori.
Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors  Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.
Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients  Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,
Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer  Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,
Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis  Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.
Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study  Robert J. Cerfolio, MD, Ayesha.
Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement  Heinrich Koertke, MD,
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy  Tomas Gudbjartsson,
Presentation transcript:

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng Ye, MD, Yiqing Wang, MD, Xiaoshuai Yuan, MD, Feichao Bao, MD, Wang LV, PhD, Jian Hu, MD, PhD  The Annals of Thoracic Surgery  Volume 102, Issue 2, Pages 424-432 (August 2016) DOI: 10.1016/j.athoracsur.2016.03.030 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier survival curves for patients with esophageal cancer by node classification: (A) lymph nodes metastasis (LNM), (B) positive lymph nodes ratio (LNR), (C) log odds of positive lymph nodes (LODDS). The Annals of Thoracic Surgery 2016 102, 424-432DOI: (10.1016/j.athoracsur.2016.03.030) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Distribution of (A) log odds of positive lymph nodes (LODDS) and number of lymph nodes metastasis (LNM) (r = 0.762; p < 0.001) and (B) LODDS and positive lymph node ratio (LNR) (r = 0.880; p < 0.001). (Spearman rank test). The Annals of Thoracic Surgery 2016 102, 424-432DOI: (10.1016/j.athoracsur.2016.03.030) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Log hazard ratio as function of (A) number of lymph node metastases (LNM), (B) positive lymph node ratio (LNR), (C) log odds of positive lymph nodes (LODDS), (D) no lymph nodes involved (n = 1,926), and (E) all nodes involved of LODDS individually (n = 404). Dotted lines indicate the 95% confidence interval. The Annals of Thoracic Surgery 2016 102, 424-432DOI: (10.1016/j.athoracsur.2016.03.030) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Supplementary Fig S1 The Annals of Thoracic Surgery 2016 102, 424-432DOI: (10.1016/j.athoracsur.2016.03.030) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Supplementary Fig S2 The Annals of Thoracic Surgery 2016 102, 424-432DOI: (10.1016/j.athoracsur.2016.03.030) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions